These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 146056)
1. Topical bioavailability of a potential anti-acne agent (SC-23110) as determined by cumulative excretion and areas under plasma concentration time curves. Wester RC; Noonan PK J Invest Dermatol; 1978 Feb; 70(2):92-4. PubMed ID: 146056 [TBL] [Abstract][Full Text] [Related]
2. In vivo percutaneous absorption of acetochlor in the rhesus monkey: dose-response and exposure risk assessment. Wester RC; Melendres JL; Maibach HI Food Chem Toxicol; 1996 Oct; 34(10):979-83. PubMed ID: 9012773 [TBL] [Abstract][Full Text] [Related]
3. Relationship of topical dose and percutaneous absorption in rhesus monkey and man. Wester RC; Maibach HI J Invest Dermatol; 1976 Oct; 67(4):518-20. PubMed ID: 823268 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism. Wester RC; Noonan PK; Smeach S; Kosobud L J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893 [TBL] [Abstract][Full Text] [Related]
5. Percutaneous absorption and excretion of alachlor in rhesus monkeys. Kronenberg JM; Fuhremann TW; Johnson DE Fundam Appl Toxicol; 1988 May; 10(4):664-71. PubMed ID: 3396793 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous absorption and excretion of xenobiotics after topical and intravenous administration to pigs. Carver MP; Riviere JE Fundam Appl Toxicol; 1989 Nov; 13(4):714-22. PubMed ID: 2620792 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous absorption of testosterone in the newborn rhesus monkey: comparison to the adult. Wester RC; Noonan PK; Cole MP; Maibach HI Pediatr Res; 1977 Jun; 11(6):737-9. PubMed ID: 405649 [TBL] [Abstract][Full Text] [Related]
8. Species differences in the metabolism and disposition of spironolactone. Karim A; Kook C; Zitzewitz DJ; Zagarella J; Doherty M; Campion J Drug Metab Dispos; 1976; 4(6):547-55. PubMed ID: 11976 [TBL] [Abstract][Full Text] [Related]
9. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats. Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin. Yu Z; Sefton J; Lew-Kaya D; Walker P; Yu D; Tang-Liu DD Clin Pharmacokinet; 2003; 42(10):921-9. PubMed ID: 12885265 [TBL] [Abstract][Full Text] [Related]
11. Influence of the size of the area of treatment on percutaneous absorption of estradiol in the rat. Chanez JF; de Lignières B; Marty JP; Wepierre J Skin Pharmacol; 1989; 2(1):15-21. PubMed ID: 2627411 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris. Thiboutot DM; Willmer J; Sharata H; Halder R; Garrett S Clin Pharmacokinet; 2007; 46(8):697-712. PubMed ID: 17655376 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis. Tang-Liu DD; Matsumoto RM; Usansky JI Clin Pharmacokinet; 1999 Oct; 37(4):273-87. PubMed ID: 10554045 [TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro percutaneous absorption of [14C]pyrene in Sprague Dawley male rats: skin reservoir effect and consequence on urinary 1-OH pyrene excretion. Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Ferrari E Arch Toxicol; 2008 Oct; 82(10):739-47. PubMed ID: 18421439 [TBL] [Abstract][Full Text] [Related]
15. In vivo percutaneous absorption of hydrocortisone: multiple-application dosing in man. Melendres JL; Bucks DA; Camel E; Wester RC; Maibach HI Pharm Res; 1992 Sep; 9(9):1164-7. PubMed ID: 1409398 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous absorption of salicylic acid after repeated (14-day) in vivo administration to normal, acnegenic or aged human skin. Davis DA; Kraus AL; Thompson GA; Olerich M; Odio MR J Pharm Sci; 1997 Aug; 86(8):896-9. PubMed ID: 9269866 [TBL] [Abstract][Full Text] [Related]
17. Effects of anatomical site and occlusion on the percutaneous absorption and residue pattern of 2,6-[ring-14C]parathion in vivo in pigs. Qiao GL; Chang SK; Riviere JE Toxicol Appl Pharmacol; 1993 Sep; 122(1):131-8. PubMed ID: 8378927 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo percutaneous absorption of 14C-octamethylcyclotetrasiloxane (14C-D4) and 14C-decamethylcyclopentasiloxane (14C-D5). Jovanovic ML; McMahon JM; McNett DA; Tobin JM; Plotzke KP Regul Toxicol Pharmacol; 2008 Mar; 50(2):239-48. PubMed ID: 18178298 [TBL] [Abstract][Full Text] [Related]